– Britain’s medicines regulator on Friday authorized Novavax’s COVID-19 vaccine for kids aged between 12 and 17 years.
The mRNA vaccines made by Moderna in addition to the partnership between Pfizer-BioNTech are additionally cleared to be used by this age group, the Medicines and Healthcare merchandise Regulatory Company (MHRA) stated.
Britain in February cleared Novavax’s two-dose vaccine, Nuvaxovid, to be used in adults.
Post a Comment